QL1706 Plus Chidamide, AG as First-line Treatment for Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE3
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Probiotics in Advanced Urothelial Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
- Status
- RECRUITING
- Phase
- PHASE3
Metastatic Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
HYPERION CCA: a Phase 2 Trial of Systemic Therapy With or Without Liver-directed Radiation Therapy for Patients With Advanced Intrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of Single Tremelimumab With Regular Interval Durvalumab Plus Gemcitabine and Cisplatin in Locally Advanced Unresectable/Metastatic Combined Hepatocellular-cholangiocarcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
GAPP Induction and Concurrent Chemoradiotherapy Followed by Toripalimab Maintenance for Nasopharyngeal Carcinoma.
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Status
- RECRUITING
- Phase
- PHASE3
Investigation of the Optimal Duration of Neoadjuvant Therapy for Resectable Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab (MK-3475) Plus Investigational Agents in Resectable Non-small Cell Lung Cancer (NSCLC) (MK-3475-01E/KEYMAKER-U01)
- Status
- RECRUITING
- Phase
- PHASE2
Study of NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Status
- RECRUITING
- Phase
- PHASE2